University of Sheffield Featured PhD Programmes
Imperial College London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Bristol Featured PhD Programmes
"information" AND "studie…×
10 miles

Cancer / Oncology (information studies) PhD Projects, Programs & Scholarships

We have 64 Cancer / Oncology (information studies) PhD Projects, Programs & Scholarships

  • "information" AND "studies" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 10 of 64
  Development of novel cancer treatments: structural studies of Nectin 4 in complex with bespoke anti-cancer peptides – to start October 2019 - for an MSc by Dissertation (MSD)
  Dr F Prischi, Dr V Bavro
Application Deadline: 1 July 2019

Funding Type

PhD Type

Scientific background. This project targets the current gap in therapeutic approaches targeting Triple Negative Breast Cancer (TNBC) that, unlike other breast cancer subtypes, lacks recommended chemotherapy treatment.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  Control of tissue growth and cancer by the Hippo pathway
  Dr K. Harvey, Dr C Poon
Applications accepted all year round

Funding Type

PhD Type

A new frontier in biomedical research will involve watching individual proteins work in real time, in living organs. Traditionally, researchers have drawn conclusions about gene function using indirect techniques that only allow us to infer what a gene normally does, without actually watching it work.
  How does amino acid metabolism affect tumour growth?
  Dr L. Cheng
Applications accepted all year round

Funding Type

PhD Type

The effect of diet on tumour growth is hotly debated but poorly characterized. Due to the heterogeneous nature of the tumours, dietary studies in patients with varied genetic background often led to inconclusive outcome.
  Metabolic rewiring in liver cancer: Role of oxidative stress and the Nrf2 pathway
  Dr A. Cox
Applications accepted all year round

Funding Type

PhD Type

Many of the major risks factors for developing liver cancer such as alcohol, obesity, smoking and toxin exposure share in common a role for oxidative stress.
  Radiomics for cancer diagnosis and patient outcome prediction
  Dr J Korte, Dr N Hardcastle
Applications accepted all year round

Funding Type

PhD Type

adiomics is an emerging field that aims to extract vital information from growing collections of medical imaging and patient data.
  Understanding the biology of male breast cancer to identify more precise ways to inform clinical decision making for personalised treatment strategies.
  Prof V Speirs, Dr R Abu Eid
Application Deadline: 28 June 2019

Funding Type

PhD Type

Breast cancer (BC) affects both genders but remains understudied in men. This is a concern; research from our and other laboratories show a rise in the number of men receiving a breast cancer diagnosis over the last 3 decades.
  Patient experience of the Mesothelioma Stratified Therapy Trial (MiST): a qualitative study
  Prof A Tod, Dr B Taylor
Application Deadline: 3 July 2019

Funding Type

PhD Type

This PhD provides a unique opportunity for a student to conduct a qualitative patient experience health services research study within a complex stratified clinical trial for people with malignant mesothelioma (MM), the Mesothelioma Stratified Therapy Trial (MiST).
  Activation of targeted DNA Damage Response as a novel therapy for Ovarian Cancer
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round

Funding Type

PhD Type

High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer and accounts for 70% of all ovarian cancer deaths.
  How is fate determined during T cell development, leukemogenesis and responses?
  Dr S. Russell
Applications accepted all year round

Funding Type

PhD Type

Understanding how cell fate programming works will lead to improved diagnostic and therapeutic opportunities for leukemia, and to improved immunotherapies for cancer and infectious disease.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.